文献速递糖尿病

HLA II类等位基因分析提示1型糖尿病与非胰岛素治疗2型糖尿病存在共同遗传组分

HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non-Insulin-Treated Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

研究纳入德国莱比锡三个队列共10413人,采用1000 Genome插补HLA基因型至4位点水平,分析其与2型糖尿病及代谢性状的关联。荟萃分析显示HLA-DRB5缺失与2型糖尿病风险升高相关(P=0.001),HLA-DQB*06:02和HLA-DQA*01:02有保护作用(P=0.005和0.003),DRB1*15:01~DQA1*01:02~DQB1*06:02单倍型与风险降低相关(OR 0.84;P=0.005),而DRB1*07:01~DQA1*02:01~DQB1*03:03为非胰岛素治疗糖尿病风险单倍型(OR 1.37;P=0.002)。结论提示HLA II类区域遗传变异对非胰岛素治疗2型糖尿病有风险和保护效应,1型和2型糖尿病可能共享HLA II类位点遗传组分。

要点

  • HLA-DRB5缺失与2型糖尿病风险升高相关(P=0.001)。
  • HLA-DQB*06:02和HLA-DQA*01:02对2型糖尿病有保护作用(P=0.005和0.003)。
  • DRB1*15:01~DQA1*01:02~DQB1*06:02单倍型与2型糖尿病风险降低相关(OR 0.84;P=0.005)。

核心结论

  • HLA II类位点遗传变异对非胰岛素治疗2型糖尿病发挥风险和保护效应,1型和2型糖尿病可能在HLA II类位点共享共同遗传组分。

研究设计与样本

  • 研究纳入来自德国莱比锡的三个队列:LIFE-Adult(N=4649)、LIFE-Heart(N=4815)和Sorbs队列(N=949),总计N=10413。
  • 所有受试者均有详细代谢表型和全基因组单核苷酸多态性(SNP)数据,使用1000 Genome插补数据将HLA基因型插补至4位点水平,并进行2型糖尿病及相关代谢性状的关联检验。

主要发现

  • 在包含所有3个队列的荟萃分析中,HLA-DRB5缺失与2型糖尿病风险升高相关(P=0.001)。
  • HLA-DQB*06:02和HLA-DQA*01:02对2型糖尿病有保护作用(P=0.005和0.003)。
  • DRB1*15:01~DQA1*01:02~DQB1*06:02单倍型与2型糖尿病风险降低相关(OR 0.84;P=0.005)。
  • DRB1*07:01~DQA1*02:01~DQB1*03:03被确定为非胰岛素治疗糖尿病风险单倍型(OR 1.37;P=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes. OBJECTIVES AND DESIGN: Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted. RESULTS: In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non-insulin-treated diabetes (OR 1.37; P = 0.002). CONCLUSIONS: Genetic variation in the HLA class II locus exerts risk and protective effects on non-insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jacobi T, Massier L, Klöting N, et al. HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non-Insulin-Treated Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 31974565. doi:10.1210/clinem/dgaa027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。